Connor, Clark & Lunn Investment Management (CC&L)’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-25,788
Closed -$1.01M 1559
2024
Q3
$1.01M Sell
25,788
-47,039
-65% -$1.87M ﹤0.01% 886
2024
Q2
$3.18M Buy
72,827
+32,051
+79% +$1.55M 0.01% 537
2024
Q1
$1.95M Buy
40,776
+5,216
+15% +$234K 0.01% 678
2023
Q4
$1.68M Buy
+35,560
New +$1.48M 0.01% 705
2019
Q2
Sell
-2,750
Closed -$290K 1051
2019
Q1
$290K Buy
2,750
+125
+5% +$12.6K ﹤0.01% 762
2018
Q4
$220K Buy
+2,625
New +$238K ﹤0.01% 832

Other funds holding NGVT

Connor, Clark & Lunn Investment Management (CC&L)'s NGVT Position: Q4 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Ingevity (NGVT) in Q4 2024, closing a stake of 25,788 shares — an estimated $1.01M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NGVT in Q4 2018 and held it in 6 quarters. The position peaked at $3.18M in Q2 2024. 257 funds tracked by Wall St. Rank hold NGVT as of Q4 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Ingevity position as of Q4 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 25,788 Ingevity shares in Q4 2024, an estimated $1.01M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Ingevity in Q4 2018 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Ingevity position peaked at $3.18M in Q2 2024.
  • 257 funds tracked by Wall St. Rank held Ingevity as of Q4 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2024, filed 10 Feb 2025.